GlassScriptPhysician profile
Dara Lee Mckinley
NPI 1346529245
$66,327.31
in general payments reported to CMS, 2019-2025
6 companies · $3,536 in 2025
The $3,536 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.80 · 2022: $5,913 · 2023: $37K · 2024: $20K · 2025: $3,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $21K · Food and Beverage: $2,711 · Honoraria: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,500.00 |
| Travel and Lodging | $20,628.29 |
| Food and Beverage | $2,710.74 |
| Honoraria | $562.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $65,104.55 | 2022-2025 | Lynparza |
| Myriad Genetic Laboratories, INC. | $773.28 | 2024-2025 | Myrisk, Precisetumor |
| Daiichi Sankyo INC. | $249.51 | 2022-2023 | Enhertu |
| Myriad Women'S Health, INC. | $141.15 | 2023 | Myrisk |
| Pfizer INC. | $44.60 | 2021-2022 | |
| Amgen INC. | $14.22 | 2023 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Mckinley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.